Compounds

Evidence-based profiles for 107 compounds

Hot & New

Weekly snapshot of compounds with the strongest recent research momentum.

Updated weekly · window Feb 21–Feb 21

107 compounds

Tirzepatide

81
fat loss
Rx

Dual GLP-1/GIP receptor agonist; GIP agonism sensitizes adipocytes and augments incretin effect beyond GLP-1 alone

Evidence

Strong evidence

Safety

Safety unknown

185 studiesn/a
10mg · Once weekly subcutaneousView

Creatine Monohydrate

78
supplement

Increases intracellular phosphocreatine, enhancing ATP resynthesis during high-intensity activity

Evidence

Strong evidence

Safety

Safety unknown

395 studiesn/a
5g · dailyView

Retatrutide

78
fat loss
Research Only

Triple GLP-1/GIP/glucagon receptor agonist; adds hepatic fat mobilization and increased energy expenditure to GLP-1/GIP incretin effects

Evidence

Strong evidence

Safety

Safety unknown

122 studiesn/a
8mg · Once weekly subcutaneous (trial doses)View

Semaglutide

78
fat loss
Rx

GLP-1 receptor agonist: delays gastric emptying, suppresses appetite via hypothalamic signaling, stimulates glucose-dependent insulin secretion

Evidence

Strong evidence

Safety

Safety unknown

495 studiesn/a
1mg · Once weekly (injection); once daily (oral Rybelsus)View

Survodutide

77
fat loss
Research Only

Dual GLP-1/glucagon receptor agonist; adds hepatic fat mobilization and increased energy expenditure to GLP-1 satiety effects

Evidence

Strong evidence

Safety

Safety unknown

148 studiesn/a
4.8mg · Once weekly subcutaneous (trial doses)View

Modafinil

76
nootropic
Rx

Weak DAT inhibition raises synaptic dopamine; activates orexin/hypocretin neurons; increases histamine and NE

Evidence

Strong evidence

Safety

Safety unknown

438 studiesn/a
200mg · once daily, morningView

HGH

76
hormonal
Rx

Binds GH receptor on hepatocytes → IGF-1 production; directly stimulates lipolysis in adipose; promotes nitrogen retention and tissue repair via IGF-1/mTOR/PI3K

Evidence

Strong evidence

Safety

Safety unknown

291 studiesn/a
2IU · Once daily subcutaneous injection (typically evening or pre-sleep)View

Citrulline Malate

76
supplement

L-citrulline converts to arginine → NO via NOS → vasodilation; malate fuels Krebs cycle ATP synthesis and accelerates ammonia clearance

Evidence

Strong evidence

Safety

Safety unknown

264 studiesn/a
8000mg · daily (45-60 min pre-workout)View

Fish Oil

76
supplement

EPA and DHA compete with arachidonic acid for COX/LOX enzymes, shifting eicosanoid production toward anti-inflammatory SPMs; DHA incorporates into cell membranes affecting fluidity and receptor function

Evidence

Strong evidence

Safety

Safety unknown

347 studiesn/a
2000mg · Once or twice daily with meals (EPA+DHA content, not total fish oil)View

Ashwagandha

75
adaptogen

Withanolides modulate HPA axis, reduce cortisol, potentiate GABA-A signaling, and inhibit NF-kB inflammation

Evidence

Strong evidence

Safety

Safety unknown

204 studiesn/a
600mg · daily (split 2x/day)View

Vitamin D3

75
vitamin mineral

Precursor to calcitriol; binds vitamin D receptor (nuclear receptor) in all cell types; regulates calcium homeostasis, immunity, muscle function, and expression of 200+ genes

Evidence

Moderate evidence

Safety

Safety unknown

472 studiesn/a
5000IU · Once daily oral with fat-containing mealView

Beta-Alanine

74
supplement

Rate-limiting carnosine precursor; muscle carnosine buffers intramuscular H+ ions during high-intensity glycolytic activity

Evidence

Moderate evidence

Safety

Safety unknown

394 studiesn/a
3200mg · daily in divided dosesView

Cerebrolysin

74
nootropic
Gray Market

Porcine brain peptide mixture with neurotrophic factor-like activity; activates BDNF/NGF signaling pathways; promotes neuroplasticity, neuronal survival, and synaptogenesis

Evidence

Moderate evidence

Safety

Safety unknown

167 studiesn/a
20ml · IV infusion or IM injection, typically in 10–20 day coursesView

Magnesium Glycinate

73
vitamin mineral

NMDA receptor voltage-dependent block, calcium channel regulation, HPA axis modulation, ATP synthesis cofactor, melatonin precursor support

Evidence

Moderate evidence

Safety

Safety unknown

376 studiesn/a
400mg · daily (evening preferred)View

L-Theanine

73
amino acid

GABA-A positive allosteric modulation, NMDA/AMPA antagonism, alpha-wave induction, catecholamine modulation

Evidence

Moderate evidence

Safety

Safety unknown

208 studiesn/a
200mg · daily or as neededView

CoQ10

73
supplement

Electron shuttle in mitochondrial ETC (complex I-III); lipophilic antioxidant protecting cell membranes; regenerates vitamins C and E; replenishes statin-depleted CoQ10

Evidence

Moderate evidence

Safety

Safety unknown

247 studiesn/a
200mg · Once or twice daily with fat-containing mealView

Berberine

72
supplement

AMPK activator; inhibits complex I of mitochondrial respiratory chain (similar to metformin); reduces hepatic gluconeogenesis; activates GLUT4 translocation; reduces intestinal glucose absorption

Evidence

Moderate evidence

Safety

Safety unknown

318 studiesn/a
1000mg · 500mg 2–3x daily with mealsView

Anavar

72
anabolic
Scheduled

Oral DHT-derived anabolic; binds AR in muscle/bone without aromatization; high anabolic-to-androgenic ratio; FDA-approved for wasting conditions

Evidence

Moderate evidence

Safety

Safety unknown

305 studiesn/a
40mg · Oral once or twice dailyView

Testosterone Cypionate

72
anabolic
Scheduled

Binds androgen receptor as full agonist; activates muscle, bone, erythropoiesis, and CNS AR programs; aromatizes to estradiol via CYP19A1

Evidence

Moderate evidence

Safety

Safety unknown

241 studiesn/a
200mg · Intramuscular injection weekly or E3.5DView

PT-141

71
peptide
Rx

MC3R and MC4R agonist in the hypothalamus; activates central arousal pathways independent of vascular mechanisms

Evidence

Moderate evidence

Safety

Safety unknown

169 studiesn/a
1.75mg · As needed, maximum 1x/24 hours, 8x/monthView

Tesamorelin

71
peptide
Rx

Stabilized GHRH analog binding pituitary GHRH receptors; stimulates GH/IGF-1 production, reducing visceral fat via lipolysis

Evidence

Moderate evidence

Safety

Safety unknown

99 studiesn/a
2mg · Once daily subcutaneousView

NAD+ Precursors

70
supplement

Orally bioavailable NAD+ precursors; NR converts to NMN then NAD+; NMN converts directly to NAD+; elevates NAD+ for sirtuin activation, PARP DNA repair, and mitochondrial biogenesis

Evidence

Moderate evidence

Safety

Safety unknown

238 studiesn/a
500mg · Once daily oral (morning)View

Methylene Blue

70
nootropic

Alternative mitochondrial electron carrier in complex I-IV chain; improves oxidative phosphorylation; MAO inhibitor; antioxidant at low doses; hormetic dose-response

Evidence

Moderate evidence

Safety

Safety unknown

231 studiesn/a
10mg · Once daily oral (avoid late evening due to potential stimulant effects)View

Tongkat Ali

68
supplement

Reduces SHBG and cortisol to free more testosterone; possible direct LH/FSH stimulation; eurycomanone (active quassinoid) drives most studied effects

Evidence

Moderate evidence

Safety

Safety unknown

193 studiesn/a
200mg · Once daily oral (standardized extract)View

Alpha-GPC

68
nootropic

Rapidly absorbed choline donor; crosses BBB and upregulates acetylcholine synthesis in cortical neurons

Evidence

Moderate evidence

Safety

Safety unknown

152 studiesn/a
600mg · dailyView

Phenylpiracetam

68
nootropic
Gray Market

Phenyl-substituted piracetam; enhances dopamine and norepinephrine activity; increases NMDA/AMPA receptor density; stimulant and cognitive-enhancing properties

Evidence

Moderate evidence

Safety

Safety unknown

204 studiesn/a
100mg · 1–2 times per week maximum (tolerance management)View

Noopept

67
nootropic
Gray Market

Dipeptide nootropic; metabolizes to cycloprolylglycine; upregulates NGF and BDNF; modulates AMPA and NMDA receptors; anxiolytic-nootropic profile

Evidence

Moderate evidence

Safety

Safety unknown

396 studiesn/a
20mg · Once or twice daily (sublingual preferred for bioavailability)View

MOTS-c

67
peptide
Research Only

Mitochondria-to-nucleus retrograde signaling via AMPK and AICAR; improves insulin sensitivity, metabolic flexibility, and exercise capacity

Evidence

Moderate evidence

Safety

Safety unknown

281 studiesn/a
10mg · Daily or 5x/week subcutaneous (research dosing from animal studies)View

LGD-4033

67
sarm
Research Only

High-affinity selective AR agonist; near-complete receptor occupancy at low doses produces significant muscle anabolism with moderate bone activation

Evidence

Moderate evidence

Safety

Safety unknown

184 studiesn/a
10mg · Once daily oralView

SS-31

67
peptide
Research Only

Selectively partitions to inner mitochondrial membrane via cardiolipin binding; stabilizes cristae, reduces ROS, and restores ATP production efficiency

Evidence

Moderate evidence

Safety

Safety unknown

208 studiesn/a
40mg · Once daily subcutaneous (clinical trial dose)View

Nandrolone Phenylpropionate

67
anabolic
Scheduled

Highly anabolic 19-nor androgen; partial AR agonist with progestogenic activity; minimal aromatization; high anabolic-to-androgenic ratio via tissue-specific AR binding

Evidence

Moderate evidence

Safety

Safety unknown

299 studiesn/a
300mg · Twice weekly intramuscular injectionView

Ostarine

67
sarm
Research Only

Selective AR agonist with tissue selectivity for muscle and bone over prostate and sebaceous glands; anabolic without full androgenic activity

Evidence

Moderate evidence

Safety

Safety unknown

152 studiesn/a
20mg · Once daily oralView

NSI-189

67
nootropic
Research Only

Stimulates hippocampal neurogenesis via unknown mechanism; increases stem cell proliferation and differentiation; demonstrated hippocampal volume increase on MRI in Phase I

Evidence

Moderate evidence

Safety

Safety unknown

255 studiesn/a
80mg · Once or twice daily oralView

Lion's Mane

67
nootropic

Hericenones and erinacines stimulate NGF and BDNF synthesis, promoting neuroplasticity, myelination, and neuroprotection

Evidence

Moderate evidence

Safety

Safety unknown

153 studiesn/a
1000mg · daily (split 2x/day)View

9-MBC

67
nootropic
Research Only

MAO-A/B inhibitor; promotes dopaminergic neuron proliferation and differentiation; neuroprotective in MPTP Parkinson's models; increases BDNF and GDNF expression (preclinical only)

Evidence

Moderate evidence

Safety

Safety unknown

107 studiesn/a
15mg · Once daily or every other day; extreme caution — no human dataView

MK-677

66
gh secretagogue
Research Only

Ghrelin receptor (GHSR-1a) agonist; stimulates pulsatile GH release from anterior pituitary; elevates IGF-1 without suppressing endogenous GH axis

Evidence

Moderate evidence

Safety

Safety unknown

110 studiesn/a
25mg · Once daily oral (evening preferred for sleep/GH pulse alignment)View

Dihexa

66
nootropic
Research Only

Potentiates HGF/c-Met receptor signaling, dramatically enhancing synaptogenesis, dendritic spine density, and hippocampal LTP

Evidence

Moderate evidence

Safety

Safety unknown

116 studiesn/a
4mg · Daily or 3–5x/week (research dosing)View

GHK-Cu

65
peptide
Gray Market

Activates collagen synthesis and wound healing genes; broad anti-inflammatory and antioxidant effects via Nrf2 and NF-κB pathways

Evidence

Moderate evidence

Safety

Safety unknown

196 studiesn/a
2mg · Daily subcutaneous (injectable); 2x/day topicalView

CJC-1295

65
peptide
Gray Market

GHRH receptor agonist on pituitary somatotrophs; stimulates pulsatile GH release and downstream IGF-1 production

Evidence

Moderate evidence

Safety

Safety unknown

106 studiesn/a
200mcg · 1–3x/day without DAC; 1–2x/week with DACView

Primobolan

64
anabolic
Scheduled

DHT-derived anabolic; binds AR without aromatization; no estrogenic activity; anabolic with low androgenicity; notable immune-modulatory effects

Evidence

Moderate evidence

Safety

Safety unknown

78 studiesn/a
400mg · Injectable: once weekly IM. Oral: 50–150mg/dayView

BPC-157

64
peptide
Gray Market

Upregulates VEGF and GH receptors; activates FAK-paxillin tendon repair pathway; modulates NO-cGMP system

Evidence

Moderate evidence

Safety

Safety unknown

216 studiesn/a
400mcg · 1-2x/dayView

TB-500

64
peptide
Gray Market

Sequesters G-actin, promotes cell migration and angiogenesis via eNOS upregulation and anti-inflammatory cytokine modulation

Evidence

Moderate evidence

Safety

Safety unknown

180 studiesn/a
7.5mg · 2x/week (loading 4–6 weeks), then 2–2.5mg 2x/month maintenanceView

Cardarine

63
sarm
Research Only

PPARδ/β agonist; transcriptionally activates fatty acid oxidation genes (CPT1, ABCA1) in skeletal muscle; dramatically increases mitochondrial biogenesis and fat burning

Evidence

Moderate evidence

Safety

Safety unknown

200 studiesn/a
10mg · Once daily oralView

Ipamorelin

63
peptide
Gray Market

Ghrelin mimetic at GHS-R1a receptors; amplifies GH pulse without raising cortisol or prolactin

Evidence

Moderate evidence

Safety

Safety unknown

50 studiesn/a
200mcg · 2–3x/day, fasted (AM, pre-workout, before bed)View

RAD-140

61
sarm
Research Only

Potent selective AR agonist; high muscle:prostate anabolic ratio; also activates neuroprotective AR pathways in brain

Evidence

Moderate evidence

Safety

Safety unknown

39 studiesn/a
10mg · Once daily oralView

YK-11

57
sarm
Research Only

Partial AR agonist with structural similarity to DHT; upregulates Follistatin to inhibit myostatin, potentially removing the ceiling on muscle hypertrophy

Evidence

Moderate evidence

Safety

Safety unknown

23 studiesn/a
5mg · Once or twice daily oralView

Masteron

41
anabolic
Scheduled

DHT-derived androgen with intrinsic anti-estrogenic activity; no aromatization; competes with estrogen at receptor level; moderate AR agonist with hardening/drying cosmetic effects

Evidence

Early evidence

Safety

Safety unknown

4 studiesn/a
400mg · Propionate: EOD IM injection. Enanthate: twice weekly IM.View

AOD-9604

N/A
peptide
Research Only

Beta-3 adrenergic receptor agonism increases lipolysis in adipocytes; mimics GH lipolytic domain without activating somatotropic axis; may inhibit lipogenesis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mcg · 1x/day (morning, fasted)View

Acarbose

N/A
other
Rx

Competitive inhibitor of alpha-glucosidase and pancreatic alpha-amylase in small intestine; delays breakdown of complex carbs to glucose; reduces postprandial glucose spike by 30-50%; modifies gut microbiome

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
100mg · 3x/day with first bite of each mealView

Acetyl-L-Carnitine

N/A
amino acid

Acetyl donor for acetylcholine synthesis; mitochondrial membrane repair; NGF signaling; carnitine palmitoyltransferase support for beta-oxidation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1500mg · 1-2x/dayView

Alpha-Lipoic Acid

N/A
supplement

Mitochondrial PDH/KGDH cofactor; recycles vitamins C, E, Q10, and glutathione; activates AMPK; Nrf2 induction; inhibits NF-kB; chelates heavy metals

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
600mg · 2-3x/day (racemic) or 1-2x/day (R-ALA)View

Anastrozole

N/A
hormonal
Rx

Reversible competitive inhibitor of aromatase (CYP19A1); blocks conversion of testosterone → estradiol; reduces circulating estrogen by 70-80% in men

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
0.5mg · every other day to twice weeklyView

Andarine (S4)

N/A
sarm
Research Only

Full agonist at androgen receptor in muscle/bone; partial agonist at AR in prostate and eye; promotes nitrogen retention, protein synthesis; fat oxidation via beta-AR upregulation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
50mg · daily (split 2x/day due to half-life)View

Bacopa Monnieri

N/A
nootropic

Bacosides inhibit acetylcholinesterase; induce BDNF and dendrite branching; antioxidant via SOD/CAT induction; serotonin 5-HT3 antagonism; cortisol reduction

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
450mg · dailyView

Boron

N/A
vitamin mineral

Inhibits SHBG production in liver; activates CYP27B1 for vitamin D conversion; modulates sex steroid binding; supports bone calcium retention

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
10mg · dailyView

Boswellia

N/A
supplement

AKBA directly inhibits 5-lipoxygenase (5-LOX), preventing leukotriene B4/C4/D4 synthesis; reduces inflammatory infiltrate without COX inhibition; MMP inhibition in cartilage

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mg · 1-2x/day with mealsView

Bromantane

N/A
nootropic
Gray Market

Upregulates AADC (dopa decarboxylase) gene expression; increases dopamine and serotonin synthesis capacity; non-releasing, non-reuptake mechanism; heat shock protein induction

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
50mg · 1x/day (morning)View

Clenbuterol

N/A
fat loss
BANNED

Beta-2 adrenergic receptor agonist; increases cAMP via Gs → activates PKA → phosphorylates HSL (hormone-sensitive lipase) → lipolysis; thermogenic via uncoupled mitochondrial respiration

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
80mcg · daily (in cycles of 2 weeks on/2 weeks off)View

Cordyceps

N/A
adaptogen

Cordycepin (adenosine analog) modulates adenosine receptors; adenosine 5'-monophosphate increases ATP availability; AMPK activation drives mitochondrial biogenesis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
3000mg · dailyView

Curcumin

N/A
supplement

IKKβ inhibition → NF-kB nuclear translocation block; COX-2 and 5-LOX inhibition; Nrf2 activation; AMPK activation; reduces TNF-alpha, IL-1beta, IL-6

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · 1-2x/day with mealsView

Enclomiphene

N/A
hormonal
Rx

Blocks ER-alpha in hypothalamus and pituitary, reducing estrogen negative feedback; pulsatile GnRH/LH/FSH increase drives testicular testosterone production and spermatogenesis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
25mg · dailyView

Ephedrine

N/A
fat loss
Rx

Indirect sympathomimetic (releases NE/E from presynaptic terminals); direct alpha and beta adrenergic agonism; mild MAO inhibition; increases thermogenesis, lipolysis, bronchodilation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
25mg · 3x/day (standard ECA cycle)View

Epithalon

N/A
peptide
Gray Market

Telomerase activation via epigenetic (DNA methylation) changes; pineal gland stimulation increasing melatonin; antioxidant enzyme induction; p53/Bcl-2 apoptosis modulation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
10mg · daily for 10-20 day cycles, 1-3x/yearView

Fasoracetam

N/A
nootropic
Gray Market

Upregulates mGluR2/3 (Group II metabotropic glutamate receptors); GABA-B receptor agonism (anxiolytic); choline uptake facilitation; reverses mGluR downregulation from stimulant use

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
30mg · 1-3x/dayView

Fisetin

N/A
supplement

Bcl-2/Bcl-xL/Bcl-W inhibitor (senolytic) — selectively kills senescent cells dependent on these anti-apoptotic proteins; Nrf2 activation; SIRT1 activation; mTOR inhibition

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
500mg · Senolytic: 1000-3000mg/day × 2-3 days per month; Neuroprotective: 100-500mg/dayView

GHRP-6

N/A
gh secretagogue
Research Only

Ghrelin receptor (GHSR-1a) agonist in pituitary and hypothalamus; amplifies GHRH-driven GH pulse; stimulates appetite via hypothalamic NPY/AgRP neurons

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
200mcg · 1-3x/day (pre-workout, bedtime)View

Ginkgo Biloba

N/A
nootropic

PAF (platelet-activating factor) antagonism; inhibits phosphodiesterase → increased cGMP; free radical scavenging (flavonoids); inhibits EAA receptor-mediated excitotoxicity (bilobalide)

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
240mg · 2-3x/dayView

Glycine

N/A
amino acid

Inhibitory glycine receptor agonist; NMDA co-agonist; collagen precursor; glutathione precursor via GCL; reduces core body temperature

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
3000mg · dailyView

Huperzine A

N/A
nootropic

Reversible acetylcholinesterase inhibitor (IC50 ~74nM); NMDA antagonist; upregulates NGF; protects against beta-amyloid neurotoxicity

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
100mcg · 1-2x/dayView

L-Arginine

N/A
amino acid

Substrate for eNOS, iNOS, nNOS → NO synthesis → cGMP → vasodilation; stimulates pituitary GH release; precursor for ornithine/polyamine synthesis; urea cycle component

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
6000mg · 2-3x/dayView

L-Glutamine

N/A
amino acid

Primary fuel for enterocytes and lymphocytes; precursor for glutathione; maintains tight junction integrity; nitrogen transporter

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
10000mg · 1-3x/dayView

L-Tyrosine

N/A
amino acid

Catecholamine synthesis precursor (DOPA decarboxylase pathway); thyroid hormone precursor; competes for large neutral amino acid transporter at BBB

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
2000mg · as needed (acute)View

Liothyronine (T3)

N/A
fat loss
Rx

TR-alpha and TR-beta nuclear receptor agonist → increased mitochondrial uncoupling proteins → thermogenesis; upregulates beta-adrenergic receptors; increases Na+/K+-ATPase expression

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
50mcg · 2-3x/day (short half-life requires split dosing)View

Maca

N/A
adaptogen

Macamides inhibit fatty acid amide hydrolase (FAAH), elevating endocannabinoids; glucosinolates converted to isothiocyanates; monoamine modulation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
3000mg · dailyView

Magnesium L-Threonate

N/A
vitamin mineral

Uniquely elevates cerebrospinal fluid and synaptic magnesium; increases synaptic density via NMDA receptor modulation; activates PKA/PKC signaling for synaptic plasticity

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
2000mg · dailyView

Melanotan II

N/A
peptide
Research Only

Non-selective melanocortin receptor agonist (MC1-4R); MC1R drives melanogenesis; MC3R/MC4R drive libido, appetite suppression, and pro-erectile pathways in hypothalamus

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
0.5mg · daily or every other day during loading; 2-3x/week maintenanceView

Metformin

N/A
other
Rx

AMPK activation via complex I inhibition; mTOR inhibition downstream; NF-kB suppression; GLP-1 secretion enhancement; gut microbiome modification (increases Akkermansia)

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · 1-2x/day with mealsView

N-Acetyl Cysteine

N/A
supplement

Cysteine donor for glutathione synthesis; direct thiol antioxidant; mucolytic via disulfide bond cleavage; modulates glutamate signaling via cystine-glutamate antiporter

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1200mg · 1-2x/dayView

Nandrolone Decanoate

N/A
anabolic
Rx

AR agonist with lower DHT conversion; progestogen receptor agonism; increases collagen synthesis (II and III); stimulates EPO; IGF-1 upregulation; glucocorticoid antagonism

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
400mg · weekly or twice weeklyView

Nattokinase

N/A
supplement

Direct fibrin degradation (cleaves Bβ chain); activates tissue plasminogen activator (tPA) and urokinase; degrades PAI-1; reduces blood viscosity and platelet aggregation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
4000FU · 1-2x/day (away from meals)View

Panax Ginseng

N/A
adaptogen

Ginsenosides activate glucocorticoid receptors, modulate NO production, inhibit neuroinflammation, enhance ACh signaling, support HPG axis via LH stimulation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
400mg · 1-2x/dayView

Phosphatidylserine

N/A
nootropic

Structural membrane phospholipid; activates PKC (cell signaling); inhibits cortisol release via HPA axis; supports acetylcholine and dopamine release

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mg · daily (2-3 divided doses)View

Polygala Tenuifolia

N/A
nootropic

BDNF induction via TrkB receptor; hippocampal neurogenesis promotion; AChE inhibition; sigma-1 receptor modulation; cAMP/CREB pathway activation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mg · 1-2x/dayView

Psilocybin

N/A
other
Scheduled

5-HT2A full agonist in PFC, DMN, and limbic system; increases synaptic density (rapid, AMPA-mediated); Default Mode Network (DMN) disruption; neuroplasticity via BDNF and TRKB

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
25mg · single session or every 2-4 weeks (therapeutic); 0.1-0.3mg every 3 days (microdosing)View

Pterostilbene

N/A
nootropic

SIRT1 activator (more potent than resveratrol); AMPK activation; superior BBB penetration; NF-kB inhibition; PPARα activation for fat oxidation; BDNF upregulation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
100mg · 1-2x/dayView

Quercetin

N/A
supplement

Bcl-2/Bcl-xL inhibitor (senolytic); AMPK activator; SIRT1 activator; zinc ionophore; NF-kB inhibitor; 5-lipoxygenase and COX inhibitor; mast cell stabilizer

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · daily for inflammation; intermittent (3 days on/4 weeks off) for senolytic protocolView

Rapamycin

N/A
other
Rx

FKBP12 binding → mTORC1 inhibition → reduced protein synthesis, increased autophagy, reduced senescence-associated secretory phenotype (SASP), improved lysosomal function

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
5mg · once weekly or every 2 weeks (off-label longevity protocol)View

Resveratrol

N/A
supplement

SIRT1 deacetylase activation (caloric restriction mimetic); AMPK activation; NF-kB inhibition; eNOS upregulation; autophagy induction; aromatase inhibition

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
500mg · 1-2x/day with mealsView

Rhodiola Rosea

N/A
adaptogen

Inhibits MAO-A/B (mild); modulates stress kinases (JNK, AMPK); upregulates SDF-1/HSP70 stress proteins; increases serotonin, dopamine, norepinephrine availability

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
400mg · 1-2x/dayView

S-23

N/A
sarm
Research Only

Full agonist at AR in muscle and bone; near-complete LH/FSH suppression via hypothalamic/pituitary AR activation; partial agonist in prostate; no aromatization

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
20mg · daily (split 2x/day)View

SR9009

N/A
sarm
Research Only

Rev-Erbα/β nuclear receptor agonist; represses BMAL1/CLOCK circadian transcription; upregulates mitochondrial biogenesis and fatty acid oxidation genes; suppresses gluconeogenesis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
20mg · 3-4x/day (short half-life; pre-workout timing popular)View

Schisandra

N/A
adaptogen

Schisandrins modulate NF-kB and Nrf2 pathways; induce CYP3A4/CYP2C19; hepatoprotective via antioxidant induction; HPA axis normalization

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · 1-2x/dayView

Selank

N/A
nootropic
Gray Market

Enkephalinase inhibition increases endogenous enkephalins; GABA-A modulation without direct binding; BDNF induction; IL-6/interferon modulation; serotonin normalization

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
750mcg · 1-3x/dayView

Semax

N/A
nootropic
Gray Market

BDNF/CNTF upregulation in hippocampus; D-Asp-HFP sequence binds melanocortin MC4R; modulates dopaminergic and serotonergic systems; anti-inflammatory via IL-6 reduction

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
600mcg · 1-3x/dayView

Sermorelin

N/A
gh secretagogue
Rx

GHRH receptor agonist in anterior pituitary somatotrophs; increases cAMP via Gs-coupled receptor; amplifies pulsatile GH release; preserves hypothalamic-pituitary axis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mcg · daily (bedtime)View

Spermidine

N/A
supplement

Inhibits EP300 acetyltransferase → Nrf2 and LC3 deacetylation → autophagy induction; eIF5A hypusination for translation of specific proteins; anti-inflammatory via NF-kB suppression

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
3mg · dailyView

Stanozolol

N/A
anabolic
Scheduled

AR agonist with DHT backbone; potent SHBG competitor; displaces testosterone from SHBG increasing free T; C17-alpha alkylated (oral) for oral bioavailability causing hepatotoxicity

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
50mg · daily (oral) or every other day (injectable)View

Tadalafil

N/A
hormonal
Rx

Selective PDE5 inhibitor; prevents cGMP degradation in vascular smooth muscle → eNOS-derived NO maintains vasodilation → sustained vasodilation in penile corpus cavernosum, pulmonary vasculature, prostate

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
5mg · daily (5mg) or as needed (10-20mg)View

Taurine

N/A
amino acid

Osmoregulation, membrane stabilization, mitochondrial quality control, GABA-A modulation, antioxidant via bile salt conjugation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
2000mg · 1-3x/dayView

Testosterone Enanthate

N/A
anabolic
Rx

Binds androgen receptor; drives muscle protein synthesis via mTOR/PI3K/Akt; inhibits glucocorticoid receptors; erythropoietin stimulation; aromatizes to estradiol

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
200mg · weekly or twice weeklyView

Testosterone Propionate

N/A
anabolic
Rx

Esterified testosterone cleaved by esterases → free testosterone; identical mechanism to other testosterone esters; ester length determines release rate and half-life only

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
100mg · every other day (EOD)View

Thymosin Alpha-1

N/A
peptide
Rx

TLR2/9 agonism activates dendritic cells; T-cell differentiation (Th1 skew) via IL-12/IFN-γ; NK cell maturation; upregulates MHC class I expression on tumor cells

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1.6mg · 2x/week to daily depending on indicationView

Trenbolone Acetate

N/A
anabolic
Scheduled

Highly potent AR agonist (5x testosterone affinity); direct IGF-1 upregulation; glucocorticoid receptor competition; does not aromatize; progestogenic activity

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
300mg · every other day (EOD) due to short half-lifeView

Urolithin A

N/A
supplement

Selective mitophagy induction via PINK1/Parkin pathway; upregulates mitochondrial biogenesis via PGC-1alpha; reduces IL-6, TNF-alpha, CRP; extends lifespan in C. elegans, rodents

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · dailyView

Vitamin C

N/A
vitamin mineral

Collagen prolyl and lysyl hydroxylase cofactor; reduces ferric to ferrous iron for absorption; recycles oxidized glutathione and vitamin E; supports catecholamine synthesis

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
1000mg · 1-2x/dayView

Vitamin K2

N/A
vitamin mineral

Cofactor for gamma-glutamyl carboxylase; activates MGP (prevents arterial calcification) and osteocalcin (bone mineralization, glucose metabolism)

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
200mcg · dailyView

Zinc

N/A
vitamin mineral

Cofactor for >300 enzymes; 5α-reductase and aromatase inhibition; androgen receptor signaling; thymulin production for T-cell maturation

Evidence

No score yet

Safety

Safety unknown

No studies yetn/a
30mg · dailyView